Cargando…
FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
Disclosure: M. Varma: None. M. Eghbali: None. D. Hung: None. A. Sahai: None. Background: Metformin, commonly used medication to treat Type II Diabetes Mellitus (DM) improves insulin sensitivity, reduces glucose production in liver and absorption by intestines. Type II DM patients often have higher B...
Autores principales: | Varma, Madhu, Eghbali, Mason, Hung, Derek, Sahai, Anurag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553648/ http://dx.doi.org/10.1210/jendso/bvad114.855 |
Ejemplares similares
-
FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023) -
FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control
por: Phadke, Dr Uday, et al.
Publicado: (2023) -
SAT-636 The Fast-Evolving Connected Diabetes Care Landscape: Transforming Diabetes Care with Telehealth and Technology
por: Levine, Brian, et al.
Publicado: (2020) -
FRI619 Kidney Magnetic Resonance Imaging Reveals Altered Tissue Architecture In Young Persons With Type 1 And 2 Diabetes
por: Wing-yiu Poon, Sarah, et al.
Publicado: (2023) -
FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
por: M, Aushili, et al.
Publicado: (2023)